Insiders · Profile

Lachey Jennifer

Chief Scientific Officer at Keros Therapeutics. Filing since 11 Feb 2021. CIK 0001808322

Company

Date

Role

Action

Shares

Amount

Of holding

KROS Keros Therapeutics, Inc.

15 Jul 2022

Chief Scientific Officer

Sold, plan not stated

46,034

$1.38M

32.6%

KROS Keros Therapeutics, Inc.

13 Jul 2022

Chief Scientific Officer

Sold, plan not stated

1,916

$57.48K

2.0%

KROS Keros Therapeutics, Inc.

11 May 2022

Chief Scientific Officer

Sold, plan not stated

5,300

$222.05K

5.8%

KROS Keros Therapeutics, Inc.

11 Apr 2022

Chief Scientific Officer

Sold, plan not stated

5,300

$332.70K

5.8%

KROS Keros Therapeutics, Inc.

4 Apr 2022

Chief Scientific Officer

Sold, plan not stated

7,950

$477.00K

8.5%

KROS Keros Therapeutics, Inc.

11 Mar 2022

Chief Scientific Officer

Sold, plan not stated

2,650

$141.45K

3.0%

KROS Keros Therapeutics, Inc.

11 Feb 2022

Chief Scientific Officer

Sold, plan not stated

2,650

$137.96K

3.0%

KROS Keros Therapeutics, Inc.

11 Jan 2022

Chief Scientific Officer

Sold, plan not stated

2,650

$142.45K

3.0%

KROS Keros Therapeutics, Inc.

5 Jan 2022

Chief Scientific Officer

Sold, plan not stated

2,650

$159.00K

3.0%

KROS Keros Therapeutics, Inc.

15 Dec 2021

Chief Scientific Officer

Sold, plan not stated

735

$36.75K

0.9%

KROS Keros Therapeutics, Inc.

13 Dec 2021

Chief Scientific Officer

Sold, plan not stated

1,915

$96.81K

2.2%

KROS Keros Therapeutics, Inc.

11 Nov 2021

Chief Scientific Officer

Sold, plan not stated

5,300

$316.06K

5.8%

KROS Keros Therapeutics, Inc.

10 Nov 2021

Chief Scientific Officer

Sold, plan not stated

15,900

$954.00K

15.6%

KROS Keros Therapeutics, Inc.

4 Nov 2021

Chief Scientific Officer

Sold, plan not stated

10,600

$530.00K

11.0%

KROS Keros Therapeutics, Inc.

11 Jun 2021

Chief Scientific Officer

Sold, plan not stated

2,650

$135.09K

3.3%

KROS Keros Therapeutics, Inc.

11 May 2021

Chief Scientific Officer

Sold, plan not stated

2,650

$132.50K

3.6%

KROS Keros Therapeutics, Inc.

12 Apr 2021

Chief Scientific Officer

Sold, plan not stated

5,300

$318.03K

6.9%

KROS Keros Therapeutics, Inc.

11 Mar 2021

Chief Scientific Officer

Sold, plan not stated

5,300

$341.75K

8.0%

KROS Keros Therapeutics, Inc.

11 Feb 2021

Chief Scientific Officer

Sold, plan not stated

5,300

$344.02K

15.9%

19 decisions on file.